Literature DB >> 3546340

Internalisation and recycling of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on a murine myelomonocytic leukemia.

F Walker, A W Burgess.   

Abstract

Radioiodinated granulocyte-macrophage colony-stimulating factor (125I-GM-CSF) binds to specific receptors (molecular weight approximately 50,000 daltons) on the murine myelomonocytic leukemia, WEHI-3BD+. At 4 degrees C 125I-GM-CSF remains on the surface of the cells and can be eluted by washing the cells with acidified isotonic buffer. When the cells are warmed to 37 degrees C, the 125I-GM-CSF is internalized rapidly (t 1/2: 7 min). The internalisation appears to be entirely receptor mediated and is independent of energy sources inhibited by sodium azide. This GM-CSF-mediated internalisation is not due to a general increase in the turnover of cell surface molecules as the specific binding of 125I-transferrin is not affected by incubation of WEHI-3BD+ cells with GM-CSF. The initial 125I released when the cells are warmed to 37 degrees C appears to be intact 125I-GM-CSF; however, after 2 h 80% of the 125I released was not precipitable with trichloroacetic acid and presumably represented degraded 125I-GM-CSF. Ammonium chloride or monensin reduced the release of 125I-GM-CSF from the cells, suggesting that the receptor-bound ligand was processed through the lysosomes. A considerable proportion of the internalised GM-CSF receptors were recycled to the surface and were available for ligand binding. Synthesis of new GM-CSF receptors contributed to the re-expression of GM-CSF receptors after down-regulation and it is possible that the GM-CSF enhances the synthesis of its own receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546340     DOI: 10.1002/jcp.1041300211

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  D E Williams; D C Bicknell; L S Park; J E Straneva; S Cooper; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells.

Authors:  S A Cannistra; P Groshek; R Garlick; J Miller; J D Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Hematopoietic growth factor receptors.

Authors:  J H Shieh; M A Moore
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

4.  Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis.

Authors:  R R Minter; E S Cohen; B Wang; M Liang; I Vainshtein; G Rees; L Eghobamien; P Harrison; D A Sims; C Matthews; T Wilkinson; P Monk; C Drinkwater; L Fabri; A Nash; M McCourt; L Jermutus; L Roskos; I K Anderson; M A Sleeman
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

5.  Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line.

Authors:  C Cardona; N M Bleehen; J G Reeve
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

Review 6.  Cytokine control of inflammation and repair in the pathology of multiple sclerosis.

Authors:  Jane M Rodgers; Stephen D Miller
Journal:  Yale J Biol Med       Date:  2012-12-13

7.  Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells.

Authors:  D Moscatelli
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

8.  Skeletal muscle healing by M1-like macrophages produced by transient expression of exogenous GM-CSF.

Authors:  Leonardo Martins; Camila Congentino Gallo; Tâmisa Seeko Bandeira Honda; Patrícia Terra Alves; Roberta Sessa Stilhano; Daniela Santoro Rosa; Timothy Jon Koh; Sang Won Han
Journal:  Stem Cell Res Ther       Date:  2020-11-06       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.